
Core Laboratories Inc. (NYSE:CLB – Free Report) – Research analysts at Zacks Research boosted their Q1 2027 earnings estimates for Core Laboratories in a research report issued to clients and investors on Wednesday, February 25th. Zacks Research analyst Team now anticipates that the oil and gas company will earn $0.19 per share for the quarter, up from their previous estimate of $0.17. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q2 2027 earnings at $0.38 EPS, Q3 2027 earnings at $0.33 EPS, Q4 2027 earnings at $0.38 EPS and FY2028 earnings at $1.74 EPS.
Core Laboratories (NYSE:CLB – Get Free Report) last posted its earnings results on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $0.01. The firm had revenue of $138.26 million during the quarter, compared to analyst estimates of $130.40 million. Core Laboratories had a net margin of 6.04% and a return on equity of 12.09%. Core Laboratories’s revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.22 EPS. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS.
Read Our Latest Research Report on Core Laboratories
Core Laboratories Stock Down 0.3%
CLB stock opened at $17.52 on Thursday. The firm’s 50-day moving average is $18.28 and its two-hundred day moving average is $15.16. The company has a market capitalization of $815.50 million, a price-to-earnings ratio of 26.14, a price-to-earnings-growth ratio of 15.33 and a beta of 1.09. Core Laboratories has a 52 week low of $9.72 and a 52 week high of $20.36. The company has a current ratio of 2.07, a quick ratio of 1.57 and a debt-to-equity ratio of 0.39.
Core Laboratories Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, March 9th. Investors of record on Monday, February 16th will be paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, February 13th. Core Laboratories’s dividend payout ratio is presently 5.97%.
Hedge Funds Weigh In On Core Laboratories
Several hedge funds and other institutional investors have recently modified their holdings of CLB. Aster Capital Management DIFC Ltd acquired a new stake in Core Laboratories in the 4th quarter valued at about $34,000. Quarry LP increased its stake in Core Laboratories by 118.1% in the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after purchasing an additional 1,599 shares in the last quarter. CWM LLC raised its stake in Core Laboratories by 36.1% during the 4th quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after buying an additional 668 shares during the period. Hantz Financial Services Inc. lifted its holdings in shares of Core Laboratories by 124.7% during the 4th quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock valued at $51,000 after purchasing an additional 1,763 shares in the last quarter. Finally, GAMMA Investing LLC increased its position in shares of Core Laboratories by 73.3% during the fourth quarter. GAMMA Investing LLC now owns 5,157 shares of the oil and gas company’s stock worth $83,000 after acquiring an additional 2,181 shares in the last quarter. Institutional investors own 97.81% of the company’s stock.
About Core Laboratories
Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.
The company’s portfolio spans two primary service lines: reservoir description and production enhancement.
Featured Stories
- Five stocks we like better than Core Laboratories
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- REVEALED: Something Big Happening Behind White House Doors
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Why the Smart Money Is Looking Beyond Single-Metal Stories
- Read this or regret it forever
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
